Showing results (211-220 of 403) with videos related to

Sort By:
Pageof 41
Diagnostic Microbiology and Infectious Disease|October 12, 2004
Bacteremia in a patient with colonic carcinoma caused by a novel Sedimentibacter species: Sedimentibacter hongkongensis sp. novPatrick C Y Woo, Jade L L Teng, Kit-Wah Leung, et al.
Pharmaceutical Research|November 1, 1993
Application of dual radiotelemetric technique in studying drug-drug interaction between diclofenac sodium and ranitidine HCl in volunteersC Alioth, R A Blum, D T D'Andrea, et al.
The Journal of International Medical Research|November 29, 2011
Low prevalence of human papillomavirus (HPV) in Chinese patients with breast cancerX Mou, L Chen, F Liu, et al.
Genome Announcements|May 23, 2015
Draft Genome Sequence of Catabacter hongkongensis Type Strain HKU16T, Isolated from a Patient with Bacteremia and Intestinal ObstructionSusanna K P Lau, Jade L L Teng, Yi Huang, et al.
Oncoimmunology|February 5, 2019
Batf3<sup>+</sup> DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapyJing Liu, Elisa A Rozeman, Jake S O'Donnell, et al.
Genome Biology and Evolution|October 22, 2014
Phylogenomic and MALDI-TOF MS analysis of Streptococcus sinensis HKU4T reveals a distinct phylogenetic clade in the genus StreptococcusJade L L Teng, Yi Huang, Herman Tse, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Lobeline inhibits the neurochemical and behavioral effects of amphetamineD K Miller, P A Crooks, L Teng, et al.
Nature Medicine|June 30, 2015
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseasesMichele W L Teng, Edward P Bowman, Joshua J McElwee, et al.
Molecular Pathology : MP|February 1, 2003
Pseudobacteraemia in a patient with neutropenic fever caused by a novel paenibacillus species: Paenibacillus hongkongensis sp. novJ L L Teng, P C Y Woo, K W Leung, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2011
FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivoK Jin, K He, F Teng, et al.
Pageof 41